Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Agilon Health (AGL) Interest Expenses (2020 - 2025)

Agilon Health (AGL) has disclosed Interest Expenses for 6 consecutive years, with $1.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Interest Expenses rose 9.02% year-over-year to $1.7 million, compared with a TTM value of $6.6 million through Dec 2025, up 7.51%, and an annual FY2025 reading of $6.6 million, up 7.51% over the prior year.
  • Interest Expenses was $1.7 million for Q4 2025 at Agilon Health, down from $1.8 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $2.9 million in Q1 2021 and bottomed at $840000.0 in Q4 2021.
  • Average Interest Expenses over 5 years is $1.5 million, with a median of $1.6 million recorded in 2024.
  • Peak annual rise in Interest Expenses hit 98.57% in 2022, while the deepest fall reached 70.38% in 2022.
  • Year by year, Interest Expenses stood at $840000.0 in 2021, then soared by 98.57% to $1.7 million in 2022, then grew by 19.48% to $2.0 million in 2023, then fell by 21.02% to $1.6 million in 2024, then rose by 9.02% to $1.7 million in 2025.
  • Business Quant data shows Interest Expenses for AGL at $1.7 million in Q4 2025, $1.8 million in Q3 2025, and $1.6 million in Q2 2025.